BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12870354)

  • 21. Presence and possible significance of immunohistochemically demonstrable metallothionein expression in pterygium versus pinguecula and normal conjunctiva.
    Tsironi S; Ioachim E; Machera M; Aspiotis M; Agnanti N; Psilas K
    Eye (Lond); 2001 Feb; 15(Pt 1):89-96. PubMed ID: 11318304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Claudin-1 expressions decrease in pterygium with respect to normal conjunctiva.
    Dogan AS; Onder E; Arikok AT; Bicer T; Gurdal C
    Cutan Ocul Toxicol; 2016 Dec; 35(4):315-8. PubMed ID: 26820697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia.
    Lee DH; Cho HJ; Kim JT; Choi JS; Joo CK
    Cornea; 2001 Oct; 20(7):738-42. PubMed ID: 11588427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
    Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
    Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium.
    Tan DT; Lim AS; Goh HS; Smith DR
    Am J Ophthalmol; 1997 Mar; 123(3):404-5. PubMed ID: 9063255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the expression of CD30 in pterygia compared to healthy conjunctivas.
    Garfias Y; Bautista-De Lucio VM; García C; Nava A; Villalvazo L; Jiménez-Martínez MC
    Mol Vis; 2009 Oct; 15():2068-73. PubMed ID: 19862340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Expression of Aquaporin-1 and Aquaporin-3 in Pterygium.
    Ortak H; Cayli S; Ocakli S; Demir S
    Cornea; 2013 Oct; 32(10):1375-9. PubMed ID: 23974882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P63 expression in conjunctival proliferative diseases: pterygium and laryngo-onycho-cutaneous (LOC) syndrome.
    Atkinson SD; Moore JE; Shah S; Sharma A; Best RM; Leccisotti A; Alarbi M; Rimmer D; Gardiner T; Moore TC
    Curr Eye Res; 2008 Jul; 33(7):551-8. PubMed ID: 18600487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression and function of survivin during the progress of pterygium.
    Xu YX; Zhang LY; Zou DL; Liu ZS; Shang XM; Wu HP; Zhou Y; He H; Liu ZG
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8480-7. PubMed ID: 25468890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative tranilast as adjunctive therapy to primary pterygium surgery with a 1-year follow-up.
    Almeida Junior GC; Arakawa L; Santi Neto Dd; Cury PM; Lima Filho AA; Sousa SJ; Alves MR; Azoubel R
    Arq Bras Oftalmol; 2015; 78(1):1-5. PubMed ID: 25714528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of Hsp90 and Ki-67 in pterygium.
    Sebastiá R; Ventura MP; Solari HP; Antecka E; Orellana ME; Burnier MN
    Diagn Pathol; 2013 Feb; 8():32. PubMed ID: 23432803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Down-regulation of Pax6 in pterygial epithelium].
    Dong N; Li W; Wu H; Chen W; Li C; Liu Z; Qu Y; Liu Z
    Yan Ke Xue Bao; 2010 Aug; 25(1):44-7. PubMed ID: 21166041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of erythropoietin receptor in human pterygial tissues.
    Kase S; Osaki M; Jin XH; Ohgami K; Yoshida K; Saito W; Takahashi S; Nakanishi K; Ito H; Ohno S
    Int J Mol Med; 2007 Nov; 20(5):699-702. PubMed ID: 17912463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of stem cell factor in pterygium.
    Nakagami T; Watanabe I; Murakami A; Okisaka S; Ebihara N
    Jpn J Ophthalmol; 2000; 44(3):193-7. PubMed ID: 10913635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency.
    Kim KW; Park SH; Wee SW; Kim JC
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6355-62. PubMed ID: 23989187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Peroxiredoxin 2 and Vascular Endothelial Growth Factor Receptor 2 in Pterygium.
    Wang Y; Lin J; Chen L; Wang L; Hao P; Han R; Ying M; Li X
    Cornea; 2017 Jul; 36(7):841-844. PubMed ID: 28489720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
    Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
    Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue factor expression in human pterygium.
    Ando R; Kase S; Ohashi T; Dong Z; Fukuhara J; Kanda A; Murata M; Noda K; Kitaichi N; Ishida S
    Mol Vis; 2011 Jan; 17():63-9. PubMed ID: 21245964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocan Overexpression in Pterygium.
    Kiliç R; Kurt A; Tad M; Taşdemir S
    Cornea; 2017 Jun; 36(6):696-699. PubMed ID: 28410547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
    Xue C; Huang Z; Wang J; Dong Y; Zhou X
    Can J Ophthalmol; 2009 Apr; 44(2):185-8. PubMed ID: 19491953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.